Douglas Lane & Associates’s Teva Pharmaceuticals TEVA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-5,860	Closed	-$270K	–	214
2016 Q3	$270K	Sell	5,860 -775	-12%	-$35.7K	0.01%	192
2016 Q2	$333K	Buy	6,635 +2,414	+57%	+$121K	0.01%	190
2016 Q1	$226K	Buy	+4,221	New	+$226K	0.01%	204